According to a recent LinkedIn post from vopemed, the company plans to demonstrate its CLARIS technology at the SAGES 2026 conference, exhibiting within the Arthrex Endoscopy booth. The post emphasizes the event’s “Connect to Purpose” theme and links it to the challenge of turning rapid surgical innovation into trusted, deployable tools that improve patient outcomes.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights its focus on solving visualization issues in minimally invasive surgery, particularly in environments with smoke and other obstructions in the operating room. For investors, this presence alongside Arthrex at a major surgical meeting may signal strategic positioning within the MedTech and surgical AI ecosystem, potentially supporting future partnership opportunities and adoption of CLARIS if clinical and commercial traction follow.